Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 29 - Sep 3
The shelf life may fluctuate based on the conditions in which you left it
Semaglutide, a novel long-acting GLP-1RA, significantly reduces body weight, improves glucose tolerance and liver function, and reduces blood lipids in T2DM animal models with nonalcoholic liver disease [7]
Remaining upright is importantsitting or standing allows gravity to assist gastric emptying and reduces the likelihood of acid reflux
PlexusDx offers compounded semaglutide injection at a flat rate at $189/mo month-to-month, or from $149/mo on the 6-month plan, eliminating flat per-compound pricing and making GLP-1 therapy accessible without insurance or membership fees
Why it matters: Novo has struggled to stay competitive with Eli Lilly LLY in developing the next generation of obesity drugs that could improve on Lillys Zepbound, with disappointing data for phase 2 drug monlunabant in September and phase 3 GLP-1 and amylin combination cagrisema in December
US$ 28.36
US$ 22.58
US$ 23.62
US$ 21.02
